Brief: HLS Announces Reimbursement For Vascepa Under Alberta's Provincial Drug Plan
29/07/2024 11:33
July 29 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS ANNOUNCES REIMBURSEMENT FOR VASCEPA® UNDER ALBERTA'S
PROVINCIAL DRUG PLAN
* HLS THERAPEUTICS: VASCEPA TO BE AVAILABLE TO MORE THAN 90%
OF
CANADIANS WHO ARE ELIGIBLE AND COVERED BY PUBLIC OR PRIVATE PLAN
* HLS THERAPEUTICS: PLA WITH ALBERTA HEALTH IS EFFECTIVE
AUGUST 1
Source text for Eikon: ID:nCNWB9CVHa
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease